Aditxt Inc., a biotech innovation company based in Richmond, Va., has partnered with Great Lakes Medical Laboratory Inc. in Farmington Hills to bring its AditxtScore, a comprehensive immune system response monitoring tool that tracks combinations of antibody responses and neutralizing antibody responses.
The new offering makes it possible to assess the strength of an individual’s immune response to the SARS-CoV-2 virus, to Michigan.
“We were drawn to Aditxt initially because it has the most comprehensive COVID-19 immune testing solution available, allowing us to give people clarity about their individual immune response to COVID-19,” says Elizabeth Knisely, CEO of Great Lakes Medical Laboratory.
“What I did not expect was that after receiving an AditxtScore myself I would find that I had low immune response, despite being vaccinated. With so much uncertainty out there right now around a surge in breakthrough cases, we need to take the guesswork out of the equation especially for patients who are vulnerable and immunocompromised.”
Under the agreement, Great Lakes will make the AditxtScore for COVID-19 available throughout six physical locations and mobile units throughout the state. The technology differentiates itself from other antibody tests by providing a detailed view of an individual’s immune response to multiple antigens associated with COVID-19.
The level of precision in AditxtScore for COVID-19, along with its ability to measure the neutralizing activity three separate isotopes, can provide clinicians with the data they need to understand the strength and quality of each individual’s immune response to COVID-19.
This information is particularly important for the millions of immunocompromised patients who may not develop an adequate immune response from vaccination or exposure to the virus.
“While we have seen an increase in the number of COVID-19 vaccines administered in Michigan, just under half of our population is still not vaccinated and vaccine hesitancy remains a significant challenge in our rural and urban areas,” says Dr. Samar Nasry, internal medicine specialist and director of the Medical Care1 Urgent Care in Ypsilanti.
“A lot of the hesitancy we’re seeing is driven by misinformation, potential infection post vaccination, and uncertainty about individual risk. The wide availability of the AditxtScore for COVID-19 will help us address those challenges by giving people the hard facts about their immune status.”
